Search results
Found 9295 matches for
Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.
Cutting Edge speakers 2015-2019.pdf
Cutting Edge speakers 2015-2019
Mentoring Scheme Booklet for Mentors
Mentoring Scheme Booklet for Mentors
Mentoring Scheme Booklet for Mentees
Mentoring Scheme Booklet for Mentees